These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anti Saccharomyces cerevisiae Antibodies in Patients With Anti-β2 Glycoprotein I Antibodies. Mankaï A; Layouni S; Ghedira I J Clin Lab Anal; 2016 Nov; 30(6):818-822. PubMed ID: 27061484 [TBL] [Abstract][Full Text] [Related]
3. Anti-Saccharomyces cerevisiae antibodies are frequent in type 1 diabetes. Sakly W; Mankaï A; Sakly N; Thabet Y; Achour A; Ghedira-Besbes L; Jeddi M; Ghedira I Endocr Pathol; 2010 Jun; 21(2):108-14. PubMed ID: 20387011 [TBL] [Abstract][Full Text] [Related]
4. Anti-Saccharomyces cerevisiae antibodies are elevated in Graves' disease but not in Hashimoto's thyroiditis. Mankaï A; Thabet Y; Manoubi W; Achour A; Sakly W; Ghedira I Endocr Res; 2013; 38(2):98-104. PubMed ID: 22992126 [TBL] [Abstract][Full Text] [Related]
5. Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis. Makharia GK; Sachdev V; Gupta R; Lal S; Pandey RM Dig Dis Sci; 2007 Jan; 52(1):33-9. PubMed ID: 17160471 [TBL] [Abstract][Full Text] [Related]
6. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease. Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases. Saibeni S; Folli C; de Franchis R; Borsi G; Vecchi M Dig Liver Dis; 2003 Dec; 35(12):862-8. PubMed ID: 14703881 [TBL] [Abstract][Full Text] [Related]